NO20054375L - Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner - Google Patents

Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner

Info

Publication number
NO20054375L
NO20054375L NO20054375A NO20054375A NO20054375L NO 20054375 L NO20054375 L NO 20054375L NO 20054375 A NO20054375 A NO 20054375A NO 20054375 A NO20054375 A NO 20054375A NO 20054375 L NO20054375 L NO 20054375L
Authority
NO
Norway
Prior art keywords
cyano
nitro
alkoxy
anthranilate
quinolines
Prior art date
Application number
NO20054375A
Other languages
English (en)
Inventor
Jr Middleton Brawner Floyd
Scott Mason Duncan
Miguel Angel Pagan
Original Assignee
Wyeth Holdings Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Holdings Co filed Critical Wyeth Holdings Co
Publication of NO20054375L publication Critical patent/NO20054375L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Det tilveiebringes en fremgangsmåte for fremstilling av 3-cyano-6-alkoksy-7-nitro-4-kinolon-mellomprodukter anvendelige for fremstilling av proteintyrosinkinase-(PTK)-inhibitorer som er anvendelige ved behandling av kreft med formelen: hvor R er alkyl(CrC3) fremstilt ved omsetning av et substituert antranilat med N,N-dimetylformamid dimetylacetal for å oppnå et N,N-dimetylamidin som blir kondensert med t-butylcyanoacetat for å oppnå et N-(2-cyano-2-t-butoksykarbonylvinyl)antranilat, som blir hydrolysert, hvilket gir et N-(2-cyano-2-karboksyvinyl)antranilat fulgt av dekarboksylering for å oppnå et N-(2-cyano-2-karboksyvinyl)antranilat fulgt av cyklisering for å oppnå en 3-cyano-6-alkoksy-7-nitro-4-kinolon.
NO20054375A 2003-04-09 2005-09-21 Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner NO20054375L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46164703P 2003-04-09 2003-04-09
PCT/US2004/010190 WO2004092138A1 (en) 2003-04-09 2004-04-02 Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines

Publications (1)

Publication Number Publication Date
NO20054375L true NO20054375L (no) 2005-10-12

Family

ID=33299849

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054375A NO20054375L (no) 2003-04-09 2005-09-21 Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner

Country Status (21)

Country Link
US (1) US6933388B2 (no)
EP (1) EP1611103A1 (no)
JP (1) JP2006522810A (no)
KR (1) KR20050120788A (no)
CN (1) CN100376558C (no)
AR (1) AR043988A1 (no)
AU (1) AU2004230864A1 (no)
BR (1) BRPI0409134A (no)
CA (1) CA2521294A1 (no)
CL (1) CL2004000758A1 (no)
CO (1) CO5640089A2 (no)
CR (1) CR7991A (no)
EC (1) ECSP056089A (no)
EG (1) EG24122A (no)
MX (1) MXPA05010685A (no)
NI (1) NI200500175A (no)
NO (1) NO20054375L (no)
RU (1) RU2333909C2 (no)
TW (1) TW200504024A (no)
UA (1) UA80607C2 (no)
WO (1) WO2004092138A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101723854A (zh) * 2008-10-24 2010-06-09 上海特化医药科技有限公司 6-取代氨基-3-氰基喹啉类化合物的制备方法及其中间体
CN111116416B (zh) * 2019-12-30 2021-03-23 中国农业大学 一种β-氨基丙烯腈类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73073C2 (uk) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
AU6159499A (en) * 1998-09-29 2000-04-17 Wyeth Holdings Corporation Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors

Also Published As

Publication number Publication date
KR20050120788A (ko) 2005-12-23
AU2004230864A1 (en) 2004-10-28
TW200504024A (en) 2005-02-01
ECSP056089A (es) 2006-03-01
AR043988A1 (es) 2005-08-17
BRPI0409134A (pt) 2006-03-28
US20040204587A1 (en) 2004-10-14
WO2004092138A1 (en) 2004-10-28
MXPA05010685A (es) 2005-12-12
EG24122A (en) 2008-07-06
EP1611103A1 (en) 2006-01-04
CL2004000758A1 (es) 2005-02-04
NI200500175A (es) 2006-05-04
CN1771230A (zh) 2006-05-10
CN100376558C (zh) 2008-03-26
CR7991A (es) 2006-05-31
RU2005134653A (ru) 2006-03-27
RU2333909C2 (ru) 2008-09-20
JP2006522810A (ja) 2006-10-05
UA80607C2 (en) 2007-10-10
CA2521294A1 (en) 2004-10-28
US6933388B2 (en) 2005-08-23
CO5640089A2 (es) 2006-05-31

Similar Documents

Publication Publication Date Title
NL300877I2 (nl) obeticholzuur
ATE449099T1 (de) Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren
MY136959A (en) Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
NO20070917L (no) Imidazotriaziner som protein-kinaseinhibitorer
DE60130771D1 (de) Substituierte heterocyclische amide
CY1108908T1 (el) Ενωσεις κινολινονης - καρβοξαμιδης ως αγωνιστες υποδοχεων 5-ητ4
NO20062136L (no) Imidazopyrazintyrosin-kinaseinhibitorer
PL1781683T3 (pl) Sposób wytwarzania 17-winylo-trifluorometanosulfonianów jako związków pośrednich
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
ME01395B (me) Postupak za izradu (1s)-4,5-dimetoksi-1-(metilaminometil)benzociklobutanai njegovih aditivnih soli kiselina kao i njegov a primena za sintezu ivabradina i njegovih farmaceutski prihvatljivih aditivnih soli kiselina
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
HRP20060124A2 (en) Process for the preparation of n-amino substituted heterocyclic compounds
NO20063324L (no) 3-cyano-kinolinderivater med antiproliferativ aktivitet
NO20053561L (no) Mettede kinoksalinderivater og deres anvendelse som metabotrofe og glutamatreseptorligander
GEP20084494B (en) New heterocyclic carboxylic acid amide derivatives
NO20052443D0 (no) 7-fenylpyrazolpyridinforbindelser
ATE505462T1 (de) Neue biologischaktive molekü le
TW200628153A (en) Novel compounds
NO20054375L (no) Fremgangsmate for syntese av 3-cyano-6-alkoksy-7-nitro-4-kinoliner
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
EA200700767A1 (ru) Способ получения пиразолов
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
ATE239722T1 (de) Benzofurylpiperazine als serotonin-agonisten
EA200800633A1 (ru) Способ получения производных сартана и промежуточных соединений, пригодных для этого способа
EA200870405A1 (ru) Способ получения гетероциклических производных

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application